| NAME |
REVEFENACIN 175MCG/3ML SOLN,INHL,3ML |
| VA GENERIC NAME |
REVEFENACIN |
| DOSAGE FORM |
SOLN,INHL |
| FDA MED GUIDE |
Revefenacin_(Yupelri)_(2018).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
175 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| UNITS |
MCG/3ML |
| NATIONAL FORMULARY NAME |
REVEFENACIN SOLN,INHL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2018-11-29 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
REVEFENACIN 175MCG/3ML INHL SOLN 3ML |
| VA PRODUCT IDENTIFIER |
R0385 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
EA |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4038021 |
| EFFECTIVE DATE/TIME |
-
- 2018-11-29 00:00:00
- STATUS: ACTIVE
|
